reviewOrphanet Journal of Rare DiseasesJan 1, 2010GOLD OA

Fabry disease

Université de Versailles Saint-Quentin-en-Yvelines

PubMed
Indexed incrossrefdoajpubmed

Abstract

Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A activity. FD is pan-ethnic and the reported annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Classically affected hemizygous males, with no residual α-galactosidase A activity may display all the characteristic neurological (pain), cutaneous (angiokeratoma), renal (proteinuria, kidney failure), cardiovascular (cardiomyopathy, arrhythmia), cochleo-vestibular and cerebrovascular (transient ischemic attacks, strokes) signs of the disease while heterozygous females have symptoms ranging from very mild to severe. Deficient…

Citation impact

1,175
total citations
FWCI
13.93
Percentile
100%
References
438
Citations per year

Authors

1

Topics & keywords

Keywords
  • Globotriaosylceramide
  • Angiokeratoma
  • Enzyme replacement therapy
  • Fabry disease
  • Medicine
  • Disease
  • Genetic counseling
  • Genetic disorder
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.